JP2021512123A5 - - Google Patents

Info

Publication number
JP2021512123A5
JP2021512123A5 JP2020541958A JP2020541958A JP2021512123A5 JP 2021512123 A5 JP2021512123 A5 JP 2021512123A5 JP 2020541958 A JP2020541958 A JP 2020541958A JP 2020541958 A JP2020541958 A JP 2020541958A JP 2021512123 A5 JP2021512123 A5 JP 2021512123A5
Authority
JP
Japan
Prior art keywords
cancer
therapeutic composition
composition according
nucleic acid
arm region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020541958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512123A (ja
JP7409612B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016413 external-priority patent/WO2019152884A1/en
Publication of JP2021512123A publication Critical patent/JP2021512123A/ja
Publication of JP2021512123A5 publication Critical patent/JP2021512123A5/ja
Application granted granted Critical
Publication of JP7409612B2 publication Critical patent/JP7409612B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020541958A 2018-02-02 2019-02-01 トリパタイトモチーフ含有蛋白質16(trim16)シグナル伝達を誘導するための組成物及び方法 Active JP7409612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862625623P 2018-02-02 2018-02-02
US62/625,623 2018-02-02
PCT/US2019/016413 WO2019152884A1 (en) 2018-02-02 2019-02-01 Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signaling

Publications (3)

Publication Number Publication Date
JP2021512123A JP2021512123A (ja) 2021-05-13
JP2021512123A5 true JP2021512123A5 (cg-RX-API-DMAC7.html) 2022-02-03
JP7409612B2 JP7409612B2 (ja) 2024-01-09

Family

ID=67479930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020541958A Active JP7409612B2 (ja) 2018-02-02 2019-02-01 トリパタイトモチーフ含有蛋白質16(trim16)シグナル伝達を誘導するための組成物及び方法

Country Status (9)

Country Link
US (1) US20210046168A1 (cg-RX-API-DMAC7.html)
EP (1) EP3746088B1 (cg-RX-API-DMAC7.html)
JP (1) JP7409612B2 (cg-RX-API-DMAC7.html)
KR (1) KR102828978B1 (cg-RX-API-DMAC7.html)
CN (1) CN111836623A (cg-RX-API-DMAC7.html)
AU (1) AU2019215191B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020015821A2 (cg-RX-API-DMAC7.html)
RU (1) RU2020128838A (cg-RX-API-DMAC7.html)
WO (1) WO2019152884A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11679163B2 (en) 2019-09-20 2023-06-20 Hdt Bio Corp. Compositions and methods for delivery of RNA
WO2021194672A1 (en) 2020-03-23 2021-09-30 Hdt Bio Corp. Compositions and methods for delivery of rna
JP2022550454A (ja) * 2019-10-02 2022-12-01 ユニバーシティ オブ ワシントン B型肝炎ウイルス感染の治療のための組成物及び方法
EP4058581A1 (en) * 2019-11-15 2022-09-21 Infectious Disease Research Institute Rig-i agonist and adjuvant formulation for tumor treatment
EP4112665A4 (en) * 2020-03-27 2024-04-10 Mitsui Chemicals, Inc. LIGHT-CURING COMPOSITION, CURED PRODUCT AND DENTAL PRODUCT
KR20240043747A (ko) 2021-07-02 2024-04-03 예일 유니버시티 암을 치료하기 위한 조성물 및 방법
JP2024532621A (ja) 2021-08-31 2024-09-05 イエール ユニバーシティ がんを治療するための組成物および方法
AU2022352486A1 (en) 2021-09-22 2024-04-11 Hdt Bio Corp. Dried nanoparticle compositions
CA3232658A1 (en) 2021-09-22 2023-03-30 Steven Gregory REED Rna vaccines against infectious diseases
WO2023049636A2 (en) 2021-09-22 2023-03-30 Hdt Bio Corp. Cancer therapy compositions and uses thereof
JP2024535352A (ja) 2021-09-22 2024-09-30 エイチディーティー バイオ コーポレーション Sars-cov-2 rnaワクチン組成物および使用方法
AU2023228912A1 (en) 2022-03-03 2024-09-19 Yale University Humanized 3e10 antibodies, variants, and antigen binding fragments thereof
WO2026039779A1 (en) 2024-08-15 2026-02-19 Yale University Humanized 3e10 antibodies and antigen binding fragments optimized for rad51 binding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003218181A1 (en) 2002-03-15 2003-09-29 Multicell Immunotherapeutics, Inc. Immunostimulatory double stranded RNA and methods of inducing, enhancing or modulating the immune response
JP2010500011A (ja) 2006-08-08 2010-01-07 ガンサー ハートマン 5’リン酸オリゴヌクレオチドの構造および使用
BRPI1100857A2 (pt) * 2011-03-18 2013-05-21 Eduardo Nowill Alexandre agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
US9775894B2 (en) * 2013-07-09 2017-10-03 University Of Washington Through Its Center For Commercialization Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
US10624964B2 (en) * 2015-05-01 2020-04-21 The Trustees Of The University Of Pennsylvania Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs
CN117244049A (zh) * 2016-02-16 2023-12-19 哈佛学院院长等 病原体疫苗及其生产和使用方法

Similar Documents

Publication Publication Date Title
RU2020128838A (ru) Композиции и способы для индуцирования передачи сигнала белка, содержащего трехсторонний мотив, 16 (trim16)
JP2548527B2 (ja) 腫瘍壊死因子の産生を増加する方法
RU2009117325A (ru) Слитый белок теломеразной обратной транскриптазы, кодирующие его нуклеотиды и их применение
JP2019193662A5 (cg-RX-API-DMAC7.html)
Matveeva et al. Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency
JP2008056679A5 (cg-RX-API-DMAC7.html)
JP2014506913A5 (cg-RX-API-DMAC7.html)
TR200700740T2 (tr) Nogo genlerinin nükleotid ve protein dizileri ve bunlar bazında yöntemler
AR079555A1 (es) Metodos de tratamiento de la infeccion de virus de hepatitis b (hbv) y virus de hepatitis c (hcv)
CN115176009A (zh) 用于靶向pd-l1的方法和组合物
JP2021525549A5 (cg-RX-API-DMAC7.html)
JP2024513559A5 (cg-RX-API-DMAC7.html)
JP2023510121A5 (cg-RX-API-DMAC7.html)
JP2023522630A5 (cg-RX-API-DMAC7.html)
JP2003530088A5 (cg-RX-API-DMAC7.html)
JP2013511975A5 (cg-RX-API-DMAC7.html)
JP2022507373A5 (cg-RX-API-DMAC7.html)
RU2004122084A (ru) Пептиды для лечения рака, ассоциированного с папилломавирусом (hpv) человека, и других эпителиальных опухолей
JP2021536239A5 (cg-RX-API-DMAC7.html)
EP3022297A1 (en) Genetically stable oncolytic rna virus, method of manufacturing and use thereof
CN104292337A (zh) 猪融合干扰素
RU2020100072A (ru) Иммуногенные композиции, содержащие cea, muc1 и tert
JP2024503703A5 (cg-RX-API-DMAC7.html)
AU2012281131B2 (en) Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment
FI3335725T3 (fi) Pds5a-epitooppeja immuuniteetin indusoijina